Diane Koontz

2.0k total citations · 1 hit paper
18 papers, 1.1k citations indexed

About

Diane Koontz is a scholar working on Epidemiology, Molecular Biology and Rheumatology. According to data from OpenAlex, Diane Koontz has authored 18 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 6 papers in Molecular Biology and 6 papers in Rheumatology. Recurrent topics in Diane Koontz's work include Inflammatory Myopathies and Dermatomyositis (16 papers), Muscle Physiology and Disorders (6 papers) and Eosinophilic Disorders and Syndromes (6 papers). Diane Koontz is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (16 papers), Muscle Physiology and Disorders (6 papers) and Eosinophilic Disorders and Syndromes (6 papers). Diane Koontz collaborates with scholars based in United States, Canada and Belgium. Diane Koontz's co-authors include Rohit Aggarwal, Chester V. Oddis, Noreen Fertig, Dana P. Ascherman, Marc C. Levesque, Zengbiao Qi, Ann M. Reed, Mary Lucas, Elaine Cassidy and Howard E. Rockette and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Seminars in Arthritis and Rheumatism.

In The Last Decade

Diane Koontz

18 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: A randomized, placebo‐phase trial

2012 448 citations Chester V. Oddis, Ann M. Reed et al. Arthritis & Rheumatism profile →

Peers

Countries citing papers authored by Diane Koontz

Since Specialization

Citations

This map shows the geographic impact of Diane Koontz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diane Koontz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diane Koontz more than expected).

Fields of papers citing papers by Diane Koontz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diane Koontz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diane Koontz. The network helps show where Diane Koontz may publish in the future.

Co-authorship network of co-authors of Diane Koontz

This figure shows the co-authorship network connecting the top 25 collaborators of Diane Koontz. A scholar is included among the top collaborators of Diane Koontz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diane Koontz. Diane Koontz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Abatacept for the treatment of myositis-associated interstitial lung disease 2025 ·Lara D. Veeken ·Rohit Aggarwal, (unknown), (unknown), Siamak Moghadam‐Kia, Sangmee Bae, Jesse Wilkerson, Didem Saygın, Galina Marder, Swamy Venuturupalli, Paul F. Dellaripa, Sonye K. Danoff, Tracy J. Doyle, Gary M. Hunninghake, Joyce Lee, Aryeh Fischer, Jeremy Falk, Cheilonda Johnson, Diane Koontz, Dana P. Ascherman, Chester V. Oddis	2
2	Design of a randomised controlled hybrid trial of nintedanib in patients with progressive myositis-associated interstitial lung disease 2024 ·BMC Pulmonary Medicine ·Rohit Aggarwal, Chester V. Oddis, (unknown), Siamak Moghadam‐Kia, Didem Saygın, Daniel J. Kass, Diane Koontz, Peide Li, Craig Conoscenti, Amy L. Olson, (unknown)	4
3	Randomized Trial of Tocilizumab in the Treatment of Refractory Adult Polymyositis and Dermatomyositis 2022 ·ACR Open Rheumatology ·Chester V. Oddis, Howard E. Rockette, Lei Zhu, Diane Koontz, David Lacomis, (unknown), Siamak Moghadam‐Kia, Dana P. Ascherman, Leslie J. Crofford, Mazen M. Dimachkie, Floranne C. Ernste, (unknown), Galina Marder, Rohit Aggarwal	23
4	Consumer-based activity trackers in evaluation of physical activity in myositis patients 2021 ·Lara D. Veeken ·Didem Saygın, Bonny Rockette‐Wagner, Chester V. Oddis, (unknown), Diane Koontz, Siamak Moghadam‐Kia, Rohit Aggarwal	17
5	Reliability, validity and responsiveness of physical activity monitors in patients with inflammatory myopathy 2021 ·Lara D. Veeken ·Bonny Rockette‐Wagner, Didem Saygın, Siamak Moghadam‐Kia, Chester V. Oddis, (unknown), Yves Allenbach, (unknown), Diane Koontz, (unknown), Rohit Aggarwal	23
6	Utility of patient-reported outcomes measurement information system (PROMIS) physical function form in inflammatory myopathy 2021 ·Seminars in Arthritis and Rheumatism ·Didem Saygın, Chester V. Oddis, (unknown), Diane Koontz, Siamak Moghadam‐Kia, Kaveh Ardalan, Theresa Coles, Rohit Aggarwal	17
7	A pilot study of dimethyl fumarate in pulmonary arterial hypertension associated with systemic sclerosis 2021 ·Journal of Scleroderma and Related Disorders ·(unknown), Diane Koontz, Christina Morse, (unknown), Robyn T. Domsic, Marc A. Simon, (unknown), (unknown), (unknown), Robert W. Simms, M. Patricia George, Paul M. Hassoun, Harrison W. Farber, Robert Lafyatis	7
8	Follow-up results of myositis patients treated with H. P. Acthar gel 2020 ·Lara D. Veeken ·Didem Saygın, Chester V. Oddis, Galina Marder, Siamak Moghadam‐Kia, (unknown), (unknown), (unknown), Diane Koontz, Rohit Aggarwal	8
9	Hand-held dynamometry for assessment of muscle strength in patients with inflammatory myopathies 2020 ·Lara D. Veeken ·Didem Saygın, Chester V. Oddis, Siamak Moghadam‐Kia, Bonny Rockette‐Wagner, (unknown), Diane Koontz, Rohit Aggarwal	17
10	Anti-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) antibody in necrotizing myopathy: treatment outcomes, cancer risk, and role of autoantibody level 2019 ·Scandinavian Journal of Rheumatology ·Rohit Aggarwal, Siamak Moghadam‐Kia, David Lacomis, (unknown), (unknown), Diane Koontz, (unknown), (unknown)	28
11	Rituximab in the Treatment of Interstitial Lung Disease Associated with Antisynthetase Syndrome: A Multicenter Retrospective Case Review 2018 ·The Journal of Rheumatology ·Tracy J. Doyle, (unknown), Rachna Madan, (unknown), Elaine Fletcher, Diane Koontz, Rohit Aggarwal, Juan C. Osorio, Iván O. Rosas, Chester V. Oddis, Paul F. Dellaripa	69
12	Efficacy and safety of adrenocorticotropic hormone gel in refractory dermatomyositis and polymyositis 2017 ·Annals of the Rheumatic Diseases ·Rohit Aggarwal, Galina Marder, Diane Koontz, (unknown), Zengbiao Qi, Chester V. Oddis	37
13	Cutaneous improvement in refractory adult and juvenile dermatomyositis after treatment with rituximab 2016 ·Lara D. Veeken ·Rohit Aggarwal, Priyadarshini Loganathan, Diane Koontz, Zengbiao Qi, Ann M. Reed, Chester V. Oddis	83
14	Autoantibody levels in myositis patients correlate with clinical response during B cell depletion with rituximab 2016 ·Lara D. Veeken ·Rohit Aggarwal, Chester V. Oddis, Danielle Goudeau, Diane Koontz, Zengbiao Qi, Ann M. Reed, Dana P. Ascherman, Marc C. Levesque	76
15	A Negative Antinuclear Antibody Does Not Indicate Autoantibody Negativity in Myositis: Role of Anticytoplasmic Antibody as a Screening Test for Antisynthetase Syndrome 2016 ·The Journal of Rheumatology ·Rohit Aggarwal, (unknown), Noreen Fertig, Diane Koontz, Zengbiao Qi, Chester V. Oddis	42
16	Anti-signal recognition particle autoantibody ELISA validation and clinical associations 2014 ·Lara D. Veeken ·Rohit Aggarwal, Chester V. Oddis, Danielle Goudeau, Noreen Fertig, (unknown), Chad E. Stephens, Zengbiao Qi, Diane Koontz, Marc C. Levesque	31
17	Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients 2013 ·Annals of the Rheumatic Diseases ·Rohit Aggarwal, Elaine Cassidy, Noreen Fertig, Diane Koontz, Mary Lucas, Dana P. Ascherman, Chester V. Oddis	217
18	Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: A randomized, placebo‐phase trial breakdown → 2012 ·Arthritis & Rheumatism ·Chester V. Oddis, Ann M. Reed, Rohit Aggarwal, Lisa G. Rider, Dana P. Ascherman, Marc C. Levesque, Richard J. Barohn, Brian M. Feldman, Michael O. Harris‐Love, Diane Koontz, Noreen Fertig, Stephanie Kelley, (unknown), Frederick W. Miller, Howard E. Rockette, (unknown)	448

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact